
INNOGLY COST Action
@innoglya
Innovation with Glycans: New Frontiers from Synthesis to New Biological Targets (ex COST action)
ID: 1118064643086462976
https://innogly.eu/ 16-04-2019 08:12:38
2,2K Tweet
1,1K Followers
1,1K Following

REVIEW Nature Rev Immunol @PamSharmaMDPhD Next-generation combination approaches for immune checkpoint therapy nature.com/articles/s4159…




A new preprint is online! Ruonan Liang made a major effort to decipher how the most recent human H3N2 viruses evolved to bind "simpler" glycans compared to isolates before 2020. #glycotime biorxiv.org/content/10.110…





I am very proud to share a long story on lectins and biofilm imaging just published in JACS Au by Eva and Lisa in cooperation with many colleagues such as not here anymore Sue Kuhaudomlarp 😍 #glycotime #chembio #AMR please have a look here: pubs.acs.org/doi/10.1021/ja…



#PhDposition available in my group at the Max Planck Institute of Colloids and Interfaces! Join us to develop new #carbohydratematerials #chemistryjobs #researchjobs #glycotime jobs.mpikg.mpg.de/jobposting/a34…


🎙️#Glyco27 Speaker Spotlight: We’re thrilled to welcome Dr. Laura Kiessling, Novartis Professor of Chemistry at Massachusetts Institute of Technology (MIT) and researcher in molecular recognition and human health. Don’t miss her talk, “Human Lectins as Probes”! Register today: glyco27.org/en/begin #glycotime


A study explores how viral N-linked glycans play a role in the interaction between chloroviruses glycoproteins and key receptors of the innate immune system. Fabrizio Chiodo nature.com/articles/s4200…



